DUBLIN–(BUSINESS WIRE)–Research and Markets has actually announced the addition of the “H5N1 Infection (Avian Influenza) – Pipeline Review, H1 2016” report to their offering.
The report offers comprehensive guide on the subject of the therapeutics under progress when it come to H5N1 Infection (Avian Influenza), finish along with analysis by phase of development, drug target, mechanism of action (MoA), course of administration (RoA) and molecule type. The report additionally covers the descriptive pharmacological action of the therapeutics, its finish Study and progress record and latest news and press releases. Additionally, the report offers an summary of essential users associated with therapeutic progress when it come to H5N1 Infection (Avian Influenza) and features dormant and discontinued projects.
The report aids in determining and tracking emerging users in the Doubt and their portfolios, increases decision making capabilities and aids to develop efficient contrarily strategies to obtain competitive advantage.
Scope:
- The report offers a snapshot of the global therapeutic landscape of H5N1 Infection (Avian Influenza)
- The report reviews pipeline therapeutics when it come to H5N1 Infection (Avian Influenza) by business and universities/Study institutes based on the subject of guide derived from business and industry-personal sources
- The report covers pipeline items based on the subject of numerous stages of progress ranging from pre-registration till discovery and undisclosed stages
- The report reviews essential users entailed H5N1 Infection (Avian Influenza) therapeutics and enlists every one of their serious and minor projects
- The report assesses H5N1 Infection (Avian Influenza) therapeutics based on the subject of drug target, mechanism of action (MoA), course of administration (RoA) and molecule type
- The report summarizes every one of the dormant and discontinued pipeline projects
- The report reviews latest news related to pipeline therapeutics when it come to H5N1 Infection (Avian Influenza)
Companies Explained Include:
- Akshaya Bio Inc.
- Altimmune, Inc.
- Antigen Express, Inc.
- Aphios Corporation
- BioDiem Ltd
- CEL-SCI Corporation
- Cocrystal Pharma, Inc.
- CSL Limited
- Daiichi Sankyo Company, Limited
- iBio, Inc.
- Immunovaccine, Inc.
- Inovio Pharmaceuticals, Inc.
- Johnson & Johnson
- Kineta, Inc.
- NewLink Genetics Corporation
- Sirnaomics, Inc.
- TGV-Laboratories
- Theraclone Sciences, Inc.
- Vaxine Pty Ltd
- VaxInnate Corporation
For much more guide head to http://ift.tt/28MShj4
from Influenza – NewsBlog http://ift.tt/28QakZm
